Recent Posts
- Lawsuit Prompts U.S. State Department To Strengthen Protections Of HIV-Positive Contract Workers
- San Francisco Postpones Agency Cuts, Los Angeles AIDS Clearinghouse Closes
- Kennedy’s Contributions To HIV/AIDS, Gay Rights Policies Recalled
- Routine Circumcision Does Not Protect Against HIV For Men Who Have Sex With Men, CDC Study Finds
- NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman And BD Commemorate Opening Of New Center To Improve HIV/AIDS Treatment In The DRC
Random Posts
- Continued International Investment, Decreased Discrimination Key To Fight Against HIV/AIDS, Says U.N. Secretary-General
- HHS To Propose Removal Of HIV From List Preventing Foreigners U.S. Entry
- FDA Marks 100th HIV/AIDS Drug Authorized For Purchase Under PEPFAR
- Yale Physicians Receive $4.1 Million Grant To Study New Treatment For Alcohol-Dependent HIV-Positive Inmates Transitioning Back Into Society
- Iran's Health Ministry Releases Figures On HIV/AIDS Cases
- New Chemically-Activated Antigen Could Expedite Development Of HIV Vaccine
- TIME Examines Debate Over Using Female Condom To Fight HIV/AIDS In Uganda
- Lawsuit Prompts U.S. State Department To Strengthen Protections Of HIV-Positive Contract Workers
- Los Angeles County Health Officials Retract Report About HIV Cases In Adult Film Industry
- Some HIV-Positive People In Wales Denied Treatment For Common Conditions, Physician Says
Prescription AIDS Drugs
Contact Us
Longer, Stronger HIV Drug Regimen For Breastfeeding Women Cuts Mother-To-Child Transmission Rate, Study Finds
July 24th, 2009
| Patient / Public: |  |
|
| Health Professional: | |
|
| Article Opinions: | php?associatednewsid=158547′ rel=’nofollow’>0 posts |
“HIV infection rates among babies are significantly cut when mothers are given prolonged ARV treatment during breastfeeding,” according to findings released at the International AIDS Society conference in Cape Town, South Africa on Wednesday, Reuters reports. According to Reuters, “Key findings from the study showed that a stronger drug cocktail administered over a longer period reduced the risk of mother-to-child HIV transmission compared with the current WHO-recommended short-course ARV regimen.” Tim Farley, project leader for the “Kesho Bora” study - which was conducted at five sites in Burkina Faso, Kenya and South Africa by the WHO in partnership with several other international agencies - said, “The results of this study show an almost two-fold reduction in the risk of HIV transmission during the breastfeeding period and also [show] there is no short-term toxicity (to mothers or infants).” The WHO “is reviewing its 2006 recommendations on the use of ARVs in pregnant women, including during the breastfeeding period. New guidelines are expected to be published by the end of 2009 and will take into account emerging data,” Reuters reports (Roelf, 7/21).
This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org.
© Henry J. Kaiser Family Foundation. All rights reserved.